Exploring Nitrous Oxide as Treatment of Mood Disorders: Basic Concepts.
Peter Nagele, Charles F Zorumski, Charles R Conway
Journal of Clinical Psychopharmacology April 1, 2018 DOI: 10.1097/jcp.0000000000000837 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Key findings | Psychiatrists lack familiarity with nitrous oxide administration and regulations, which this review aims to address. |
Abstract
Nitrous oxide (laughing gas) has shown early promise as a rapidly acting antidepressant in patients with treatment-resistant major depression and is currently investigated in several clinical trials. Because nitrous oxide is rarely administered outside operating rooms or dental practices, most psychiatrists are not familiar with how nitrous oxide is administered in a medical setting and what regulations guide its use. The goal of this brief review was to educate psychiatrists about the basic concepts of nitrous oxide administration and pharmacology. Furthermore, common misconceptions about nitrous oxide will be discussed.
Citations in the library
Cited by 25
- Novel drug developmental strategies for treatment‐resistant depression British Journal of Pharmacology November 25, 2021
- The role of neurotrophic factors in novel, rapid psychiatric treatments. Neuropsychopharmacology 2024
- Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder Journal of Experimental Pharmacology 2021
- Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial Brazilian Journal of Psychiatry February 18, 2021
- Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review Frontiers in Psychiatry May 26, 2022
and 20 more in the library
Cites 10
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders JAMA Psychiatry March 1, 2017
- Side-effects associated with ketamine use in depression: a systematic review. The Lancet Psychiatry 2018
- Nitrous oxide speeds the reduction of distressing intrusive memories in an experimental model of psychological trauma Psychological Medicine March 3, 2016
- The Subjective Response to Nitrous Oxide is a Potential Pharmaco-Endophenotype for Alcohol Use Disorder: A Preliminary Study with Heavy Drinkers. The International Journal of Neuropsychopharmacology April 1, 2017
and 5 more in the library